BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6231743)

  • 1. [Dynamics of the peripheral blood indices in recurrent thyrotoxicosis in inhabitants of northern Europe].
    Shatsova EN
    Ter Arkh; 1984; 56(2):134-7. PubMed ID: 6231743
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dynamics of the serum lipid indices in thyrotoxicosis].
    Tsanev A; Khlebarova M; Dishlianova B; Zlateva S
    Vutr Boles; 1984; 23(3):94-9. PubMed ID: 6547793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma levels of testosterone production in male thyrotoxicosis].
    Mowszowicz I; Dray F
    Ann Biol Clin (Paris); 1967; 25(7):879-88. PubMed ID: 4864783
    [No Abstract]   [Full Text] [Related]  

  • 4. Peripheral blood leucocytes in thyrotoxicosis (Graves' disease) as studied by conventional light microscopy.
    Irvine WJ; Wu FC; Urbaniak SJ; Toolis F
    Clin Exp Immunol; 1977 Feb; 27(2):216-21. PubMed ID: 849652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The functional state of the blood clotting system in thyrotoxicosis].
    Trach BP
    Vrach Delo; 1971 Jan; (1):96-8. PubMed ID: 5576592
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood gases in patients with thyrotoxicosis during the pre- and postoperative period].
    Larionova TA
    Probl Endokrinol (Mosk); 1967; 13(1):20-5. PubMed ID: 5633268
    [No Abstract]   [Full Text] [Related]  

  • 7. Apathetic hyperthyroidism in an adolescent.
    Grewal RP
    J Psychiatry Neurosci; 1993 Nov; 18(5):276. PubMed ID: 8297926
    [No Abstract]   [Full Text] [Related]  

  • 8. The peripheral blood picture in thyrotoxicosis.
    Reddy J; Brownlie BE; Heaton DC; Hamer JW; Turner JG
    N Z Med J; 1981 Mar; 93(679):143-5. PubMed ID: 6940035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increased serum PIVKA-II levels in hyperthyroidism].
    Morimoto M; Takeda K; Ohara E; Nishimori Y; Hisahara T; Nishida M; Sugiura T
    Rinsho Byori; 2001 Nov; 49(11):1146-50. PubMed ID: 11769563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of serum creatine kinase during treatment with antithyroid drugs in patients with hyperthyroidism due to Graves disease. A novel side effect of antithyroid drugs.
    Suzuki S; Ichikawa K; Nagai M; Mikoshiba M; Mori J; Kaneko A; Sekine R; Asanuma N; Hara M; Nishii Y; Yamauchi K; Aizawa T; Hashizume K
    Arch Intern Med; 1997 Mar; 157(6):693-6. PubMed ID: 9080924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study.
    Vos XG; Smit N; Endert E; Tijssen JG; Wiersinga WM
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):311-7. PubMed ID: 18208575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood platelet count and properties of the inhabitants of the city of Kirov].
    Tkacheva TV; Novosadov VM; Kriazhev LN
    Lab Delo; 1979; (2):93-6. PubMed ID: 85754
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum calcitonin in hyperthyroidism.
    Földes J; Petrányi G; Takó J; Bános C; Krasznai I; Horváth C; Steczek K
    Acta Med Hung; 1983; 40(2-3):99-105. PubMed ID: 6689443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission of aplastic anemia induced by treatment for Graves disease in a pediatric patient.
    Das PK; Wherrett D; Dror Y
    Pediatr Blood Cancer; 2007 Aug; 49(2):210-2. PubMed ID: 16456859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood thyrotropic activity in patients with thyrotoxicosis].
    Eskin IA; Skuratova NA; Kalinin AP; Konopatskaia VM
    Probl Endokrinol (Mosk); 1967; 13(4):6-10. PubMed ID: 5633274
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prolactin content of the blood in thyrotoxicosis].
    Natarov VV; Gladkova AI; Pesotskaia PM
    Vrach Delo; 1982 Jun; (6):15-7. PubMed ID: 7113159
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperthyroidism affects arterial stiffness, plasma NT-pro-B-type natriuretic peptide levels, and subendocardial perfusion in patients with Graves' disease.
    Bodlaj G; Pichler R; Brandstätter W; Hatzl-Griesenhofer M; Maschek W; Biesenbach G; Berg J
    Ann Med; 2007; 39(8):608-16. PubMed ID: 17852031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk factors of early recurrence after surgical treatment in Graves disease].
    Kostka A
    Folia Med Cracov; 2004; 45(1-2):97-119. PubMed ID: 16276830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between diabetic ketoacidosis and thyrotoxicosis.
    Solá E; Morillas C; Garzón S; Gómez-Balaguer M; Hernández-Mijares A
    Acta Diabetol; 2002 Dec; 39(4):235-7. PubMed ID: 12486499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in blood coagulation in patients with thyrotoxicosis during preoperative management].
    Liul'ka AN; Kovalev AP
    Vestn Khir Im I I Grek; 1977 Aug; 119(8):27-32. PubMed ID: 919181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.